VJHemOnc is committed to improving our service to you

COMy Virtual 2020 | NK-cell enhancement: TRAIL variant

VJHemOnc is committed to improving our service to you

Michael O'Dwyer

Michael O’Dwyer, MD, PhD, National University of Ireland, Galway, Ireland, discusses the incorporation of a TRAIL variant into NK-cells. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter